J. Melo

New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia.

C. Sawyers, F. Frassoni, R. Hehlmann, 1997, Haematologica.

Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH‐296

J. Melo, J. Goldman, A. Miller, 1999, British journal of haematology.

Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene.

A. Hagenbeek, P. Tiberghien, C. Ferrand, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.

A. Miller, J. Apperley, J. M. Goldman, 2000, Virology.

Portofino International Conference on Chronic Myeloid Leukemia.

A. Carella, J. M. Goldman, J. Melo, 2001, Experimental hematology.

Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression

E. Nacheva, J. Apperley, C. Grace, 2007, Genes, chromosomes & cancer.

Neoplastic x and λ cells in a B‐PLL with chromosome translocations of both light chain gene regions

J. Melo, D. Catovsky, L. Foroni, 1984 .

Primitive, Quiescent and Difficult to Kill: The Role of Non-Proliferating Stem Cells in Chronic Myeloid Leukemia

J. Melo, D. J. Barnes, J. V. Melo, 2006, Cell cycle.

Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma.

J. Melo, D. Catovsky, D. Galton, 1988, Journal of clinical pathology.